These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 17711604

  • 1. Apolipoprotein E genotype and lifetime cognitive decline.
    Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG.
    Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
    [Abstract] [Full Text] [Related]

  • 2. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [Abstract] [Full Text] [Related]

  • 3. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
    Van Gerven PW, Van Boxtel MP, Ausems EE, Bekers O, Jolles J.
    Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
    [Abstract] [Full Text] [Related]

  • 4. How migraines impact cognitive function: findings from the Baltimore ECA.
    Kalaydjian A, Zandi PP, Swartz KL, Eaton WW, Lyketsos C.
    Neurology; 2007 Apr 24; 68(17):1417-24. PubMed ID: 17452587
    [Abstract] [Full Text] [Related]

  • 5. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.
    Neurology; 2004 Sep 14; 63(5):816-21. PubMed ID: 15365129
    [Abstract] [Full Text] [Related]

  • 6. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
    O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM.
    J Am Geriatr Soc; 1998 Dec 14; 46(12):1493-8. PubMed ID: 9848808
    [Abstract] [Full Text] [Related]

  • 7. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD, Fisk JD, Rockwood K.
    Dement Geriatr Cogn Disord; 2003 Dec 14; 15(1):1-5. PubMed ID: 12457072
    [Abstract] [Full Text] [Related]

  • 8. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.
    Neurology; 2000 Apr 11; 54(7):1492-7. PubMed ID: 10751265
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
    Batterham PJ, Bunce D, Cherbuin N, Christensen H.
    Am J Geriatr Psychiatry; 2013 Oct 11; 21(10):1010-9. PubMed ID: 23567378
    [Abstract] [Full Text] [Related]

  • 10. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.
    Psychol Med; 2009 Nov 11; 39(11):1907-11. PubMed ID: 19335933
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.
    Dement Geriatr Cogn Disord; 2007 Nov 11; 24(2):98-103. PubMed ID: 17596691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T, Zdanys K, Black B, Rightmer T, Grey M, Garman K, Macavoy M, Gelernter J, van Dyck C.
    Dement Geriatr Cogn Disord; 2006 Nov 11; 22(1):73-82. PubMed ID: 16699282
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA, Oulhaj A, de Jager CA, Williams JH.
    Neurology; 2005 Dec 27; 65(12):1888-93. PubMed ID: 16380608
    [Abstract] [Full Text] [Related]

  • 18. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.
    Arch Neurol; 2007 Sep 27; 64(9):1306-11. PubMed ID: 17846270
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY, Sadovnick AD, Feldman H.
    CMAJ; 2004 Oct 12; 171(8):863-7. PubMed ID: 15477624
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.